2024 annual financial data
NervGen Pharma 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -24,915,258 CAD and net income was -23,989,780 CAD.
Operating cash flow was -16,829,728 CAD.
Get free NervGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -24,915,258 CAD
- Net income
- -23,989,780 CAD
- Operating cash flow
- -16,829,728 CAD